|
Volumn 9, Issue 5, 2001, Pages 350-354
|
Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting
|
Author keywords
Antiemetics; Cisplatin; Neurokinin1 receptor antagonists; Substance P
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
CISPLATIN;
NEUROKININ 1 RECEPTOR;
NEUROKININ 1 RECEPTOR ANTAGONIST;
SUBSTANCE P;
TACHYKININ RECEPTOR;
CANCER;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG TOLERABILITY;
HUMAN;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NAUSEA AND VOMITING;
NONHUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TREATMENT OUTCOME;
CHEMICALLY INDUCED DISORDER;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
NAUSEA;
VOMITING;
ANTIEMETICS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DRUG THERAPY, COMBINATION;
HUMANS;
NAUSEA;
RECEPTORS, NEUROKININ-1;
SUBSTANCE P;
VOMITING;
|
EID: 0034742680
PISSN: 09414355
EISSN: None
Source Type: Journal
DOI: 10.1007/s005200000199 Document Type: Review |
Times cited : (50)
|
References (28)
|